John F. Deeken, MD

John Deeken, MD

John Deeken, MD

John F. Deeken, MD

Medical Oncology
Years of Experience
Clinical Interests
Head and Neck Cancer, Personalized Medicine, Pharmacogenetics

8081 Innovation Park Dr
Level 4 - White Oak Clinic
Fairfax, VA 22031


About John F. Deeken, MD

Dr. Deeken joined Inova in 2013 and currently has more than 21 years of clinical experience in internal medicine and medical oncology. He serves as the President of Inova Schar Cancer Institute (Inova Schar) and Medical Director for the Inova Schar Head and Neck Cancer Program.

His clinical research focuses on the use of immunotherapy treatments while his laboratory research takes a closer look at understanding the growing epidemic of head and neck cancers caused by HPV. This includes understanding the tumor mutations that are induced by HPV infection and how those tumors can be better treated with targeted therapies. He believes that gaining a better understanding of genomic factors may explain who might be at risk for developing HPV-caused Head and Neck cancer.

Dr. Deeken served on the national Head and Neck Cancer Scientific Committee for the American Society of Clinical Oncology (ASCO) and currently serves on ASCO’s Government Relations Committee. Prior to joining Inova, he was Director of the Head and Neck Medical Oncology Program at the Lombardi Comprehensive Cancer Center at Georgetown University and Regional Director for Medical Oncology for Medstar Health. He currently serves as Professor of Medicine at the University of Virginia.

Dr. Deeken received his Doctor of Medicine from Georgetown University, where he also did his residency in Internal Medicine. He did his fellowship training in Medical Oncology at the National Cancer Institute.

A native of Wisconsin, Dr. Deeken is married and has 4 children.

Research and Publications

View list of publications from Dr. Deeken’s research

Blog Posts

Fighting a Cancer Epidemic With a Vaccine (August 2022)

Preparing for a Shortage of Cancer Doctors (May 2019)

FDA Approves Cutting-Edge Cancer Drug from Inova Schar Cancer Institute Clinical Trial (December 2018)

The Future of Personalized Health at Inova (August 2015)

Medical School
Georgetown University School of Medicine
MedStar Georgetown University Hospital
Training Specialty: Internal Medicine
6/20/2001 - 6/30/2004
National Cancer Institute
Training Specialty: Medical Oncology
7/1/2004 - 6/30/2006

Patient Reviews

About Patient Comments

The Patient Rating score is an average of all responses to physician related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are gathered from our Press Ganey Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.